Glycogene expression alterations associated with pancreatic cancer Epithelial-mesenchymal transition in complementary model systems

PLoS ONE

Volumn 5, Issue 9, 2010, Pages

  Maupin, Kevin A ^a   Sinha, Arkadeep ^a   Eugster, Emily ^a   Miller, Jeremy ^a   Ross, Julianna ^b   Paulino, Vincent ^b   Keshamouni, Venkateshwar G ^c   Tran, Nhan ^b   Berens, Michael ^b   Webb, Craig ^a   Haab, Brian B ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN; ALPHA5 INTEGRIN; GALECTIN; GLYCOPROTEIN; HYALURONIC ACID; LAMININ; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; NOTCH RECEPTOR; OSTEONECTIN; SULFATASE; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; ZINC FINGER PROTEIN; POLYSACCHARIDE; PROTEIN;

ARTICLE; BINDING AFFINITY; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENETIC ASSOCIATION; GLYCOSYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PROTEIN BINDING; SIALYLATION; SULFATION; UPREGULATION; WESTERN BLOTTING; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOPHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; HUMANS; MODELS, BIOLOGICAL; PANCREATIC NEOPLASMS; POLYSACCHARIDES; PROTEINS;

EID: 77958516882     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013002     Document Type: Article

References (70)

1. American Cancer Society (2009) Cancer Facts and Figures. AtlantaGA: American Cancer Society.
2. Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, et al. (2007) Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res 13: 4769-4776.
3. Yeo TP, Hruban RH, Leach SD, Wilentz RE, Sohn TA, et al. (2002) Pancreatic cancer. Curr Probl Cancer 26: 176-275.
4. Rosenberg L (2000) Pancreatic cancer: a review of emerging therapies. Drugs 59: 1071-1089.
5. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, et al. (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28: 977-987.
6. Sabbah M, Emami S, Redeuilh G, Julien S, Prevost G, et al. (2008) Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 11: 123-151.
7. Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829.
8. Buck E, Eyzaguirre A, Barr S, Thompson S, Sennello R, et al. (2007) Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Mol Cancer Ther 6: 532-541.
9. Thomson S, Buck E, Petti F, Griffin G, Brown E, et al. (2005) Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res 65: 9455-9462.
10. Hruban RH, Adsay NV (2009) Molecular classification of neoplasms of the pancreas. Hum Pathol 40: 612-623.
11. Luttges J, Schemm S, Vogel I, Hedderich J, Kremer B, et al. (2000) The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol 191: 154-161.
12. Javle MM, Gibbs JF, Iwata KK, Pak Y, Rutledge P, et al. (2007) Epithelialmesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer. Ann Surg Oncol 14: 3527-3533.
13. Oida Y, Yamazaki H, Tobita K, Mukai M, Ohtani Y, et al. (2006) Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer. Oncol Rep 16: 457-463.
14. Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, et al. (2004) N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 10: 4125-4133.
15. von Burstin J, Eser S, Paul MC, Seidler B, Brandl M, et al. (2009) E-cadherin regulates metastasis of pancreatic cancer. Gastroenterology.
16. Yin T, Wang C, Liu T, Zhao G, Zha Y, et al. (2007) Expression of snail in pancreatic cancer promotes metastasis and chemoresistance. J Surg Res 141: 196-203.
17. Shah AN, Summy JM, Zhang J, Park SI, Parikh NU, et al. (2007) Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol 14: 3629-3637.
18. Lowe JB, Marth JD (2003) A genetic approach to Mammalian glycan function. Annu Rev Biochem 72: 643-691.
19. Trombetta ES, Parodi AJ (2001) N-glycan processing and glycoprotein folding. Adv Protein Chem 59: 303-344.
20. Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, et al. (2009) Essentials of Glycobiology. 2 ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
21. Ellgaard L, Molinari M, Helenius A (1999) Setting the standards: quality control in the secretory pathway. Science 286: 1882-1888.
22. Reitman ML, Varki A, Kornfeld S (1981) Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 59-diphosphate- N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity. J Clin Invest 67: 1574-1579.
23. Feizi T (1985) Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature 314: 53-57.
24. Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS (1987) Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236: 582-585.
25. Tsuboi S, Fukuda M (2001) Roles of O-linked oligosaccharides in immune responses. Bioessays 23: 46-53.
26. Buck CA, Glick MC, Warren L (1971) Glycopeptides from the surface of control and virus-transformed cells. Science 172: 169-171.
27. Muramatsu T, Muramatsu H (2004) Carbohydrate antigens expressed on stem cells and early embryonic cells. Glycoconj J 21: 41-45.
28. Capela A, Temple S (2006) LeX is expressed by principle progenitor cells in the embryonic nervous system, is secreted into their environment and binds Wnt-1. Dev Biol 291: 300-313.
29. Comelli EM, Sutton-Smith M, Yan Q, Amado M, Panico M, et al. (2006) Activation of murine CD4+ and CD8+ T lymphocytes leads to dramatic remodeling of N-linked glycans. J Immunol 177: 2431-2440.
30. Wu YM, Nowack DD, Omenn GS, Haab BB (2009) Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells. J Proteome Res 8: 1876-1886.
31. Fukuda M (1991) Leukosialin, a major O-glycan-containing sialoglycoprotein defining leukocyte differentiation and malignancy. Glycobiology 1: 347-356.
32. Comelli EM, Head SR, Gilmartin T, Whisenant T, Haslam SM, et al. (2006) A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. Glycobiology 16: 117-131.
33. Kroes RA, Dawson G, Moskal JR (2007) Focused microarray analysis of glycogene expression in human glioblastomas. J Neurochem 103 Suppl 1: 14-24.
34. Nairn AV, York WS, Harris K, Hall EM, Pierce JM, et al. (2008) Regulation of glycan structures in animal tissues: transcript profiling of glycan-related genes. J Biol Chem 283: 17298-17313.
35. Alliel PM, Perin JP, Jolles P, Bonnet FJ (1993) Testican, a multidomain testicular proteoglycan resembling modulators of cell social behaviour. Eur J Biochem 214: 347-350.
36. Demuth T, Rennert JL, Hoelzinger DB, Reavie LB, Nakada M, et al. (2008) Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines. BMC Genomics 9: 54.
37. Heiskanen A, Hirvonen T, Salo H, Impola U, Olonen A, et al. (2009) Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J 26: 367-384.
38. Julien S, Lagadec C, Krzewinski-Recchi MA, Courtand G, Le Bourhis X, et al. (2005) Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration. Breast Cancer Res Treat 90: 77-84.
39. Kariya Y, Kawamura C, Tabei T, Gu J (2010) Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3-dependent keratinocyte motility. J Biol Chem 285: 3330-3340.
40. Barthel SR, Wiese GK, Cho J, Opperman MJ, Hays DL, et al. (2009) Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc Natl Acad Sci U S A 106: 19491-19496.
41. Ricciardelli C, Sakko AJ, Ween MP, Russell DL, Horsfall DJ (2009) The biological role and regulation of versican levels in cancer. Cancer Metastasis Rev 28: 233-245.
42. Skandalis SS, Kletsas D, Kyriakopoulou D, Stavropoulos M, Theocharis DA (2006) The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer. Biochim Biophys Acta 1760: 1217-1225.
43. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, et al. (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457: 102-106.
44. Lemjabbar-Alaoui H, van Zante A, Singer MS, Xue Q, Wang YQ, et al. Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis. Oncogene 29: 635-646.
45. Nawroth R, van Zante A, Cervantes S, McManus M, Hebrok M, et al. (2007) Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells. PLoS ONE 2: e392.
46. Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD (2002) Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem 277: 49175-49185.
47. Engelholm LH, Ingvarsen S, Jurgensen HJ, Hillig T, Madsen DH, et al. (2009) The collagen receptor uPARAP/Endo180. Front Biosci 14: 2103-2114.
48. Sturge J, Wienke D, East L, Jones GE, Isacke CM (2003) GPI-anchored uPAR requires Endo180 for rapid directional sensing during chemotaxis. J Cell Biol 162: 789-794.
49. Clausen H, Bennett EP (1996) A family of UDP-GalNAc: polypeptide Nacetylgalactosaminyl- transferases control the initiation of mucin-type O-linked glycosylation. Glycobiology 6: 635-646.
50. Brockhausen I (2006) Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep 7: 599-604.
51. Sutherlin ME, Nishimori I, Caffrey T, Bennett EP, Hassan H, et al. (1997) Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines. Cancer Res 57: 4744-4748.
52. Gu C, Oyama T, Osaki T, Li J, Takenoyama M, et al. (2004) Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence. Br J Cancer 90: 436-442.
53. Onitsuka K, Shibao K, Nakayama Y, Minagawa N, Hirata K, et al. (2003) Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide Nacetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinoma. Cancer Sci 94: 32-36.
54. Miyahara N, Shoda J, Kawamoto T, Furukawa M, Ueda T, et al. (2004) Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder. Clin Cancer Res 10: 2090-2099.
55. Harduin-Lepers A, Stokes DC, Steelant WF, Samyn-Petit B, Krzewinski-Recchi MA, et al. (2000) Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6Gal- NAcIV. Biochem J 352 Pt 1: 37-48.
56. Nemoto-Sasaki Y, Mitsuki M, Morimoto-Tomita M, Maeda A, Tsuiji M, et al. (2001) Correlation between the sialylation of cell surface Thomsen-Friedenreich antigen and the metastatic potential of colon carcinoma cells in a mouse model. Glycoconj J 18: 895-906.
57. Mungul A, Cooper L, Brockhausen I, Ryder K, Mandel U, et al. (2004) Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice. Int J Oncol 25: 937-943.
58. Nakayama J, Fukuda MN, Fredette B, Ranscht B, Fukuda M (1995) Expression cloning of a human polysialyltransferase that forms the polysialylated neural cell adhesion molecule present in embryonic brain. Proc Natl Acad Sci U S A 92: 7031-7035.
59. Schreiber SC, Giehl K, Kastilan C, Hasel C, Muhlenhoff M, et al. (2008) Polysialylated NCAM represses E-cadherin-mediated cell-cell adhesion in pancreatic tumor cells. Gastroenterology 134: 1555-1566.
60. Maeda Y, Watanabe R, Harris CL, Hong Y, Ohishi K, et al. (2001) PIG-M transfers the first mannose to glycosylphosphatidylinositol on the lumenal side of the ER. Embo J 20: 250-261.
61. Almeida AM, Murakami Y, Layton DM, Hillmen P, Sellick GS, et al. (2006) Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency. Nat Med 12: 846-851.
62. Brown JR, Fuster MM, Li R, Varki N, Glass CA, et al. (2006) A disaccharidebased inhibitor of glycosylation attenuates metastatic tumor cell dissemination. Clin Cancer Res 12: 2894-2901.
63. Fuster MM, Esko JD (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5: 526-542.
64. Goss PE, Baker MA, Carver JP, Dennis JW (1995) Inhibitors of carbohydrate processing: A new class of anticancer agents. Clin Cancer Res 1: 935-944.
65. Chen WC, Completo GC, Sigal DS, Crocker PR, Saven A, et al. In vivo targeting of B-cell lymphoma with glycan ligands of CD22. Blood.
66. Chen S, LaRoche T, Hamelinck D, Bergsma D, Brenner D, et al. (2007) Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat Methods 4: 437-444.
67. Yue T, Goldstein IJ, Hollingsworth MA, Kaul K, Brand RE, et al. (2009) The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. Mol Cell Proteomics 8: 1697-1707.
68. Berens ME, Beaudry C (2004) Radial monolayer cell migration assay. Methods Mol Med 88: 219-224.
69. Mandel U, Hassan H, Therkildsen MH, Nielsen P, Rygaard J, et al. (1999) Production and characterization of monoclonal antibodies to three human members of the polypeptide GalNAc-transferase family. Glycobiology 9: 43-52.
70. Iozzo RV, ed. (2007) Proteoglycan Protocols. New York: Springer-Verlag New York, LLC.